These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22700465)

  • 21. Reasoning deficits in ecstasy (MDMA) polydrug users.
    Fisk JE; Montgomery C; Wareing M; Murphy PN
    Psychopharmacology (Berl); 2005 Sep; 181(3):550-9. PubMed ID: 16025320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verbal working memory deficits in current and previous users of MDMA.
    Wareing M; Fisk JE; Murphy P; Montgomery C
    Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is emotional intelligence impaired in ecstasy-polydrug users?
    Craig L; Fisk JE; Montgomery C; Murphy PN; Wareing M
    J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for executive deficits among users of MDMA (Ecstasy).
    Fisk JE; Montgomery C; Murphy P; Wareing M
    Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G; Redman J
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syllogistic reasoning performance in MDMA (Ecstasy) users.
    Montgomery C; Fisk JE; Newcombe R; Wareing M; Murphy PN
    Exp Clin Psychopharmacol; 2005 May; 13(2):137-45. PubMed ID: 15943546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
    Golding JF; Groome DH; Rycroft N; Denton Z
    Am J Drug Alcohol Abuse; 2007; 33(2):301-7. PubMed ID: 17497553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updating of working memory in ecstasy polydrug users: Findings from fNIRS.
    Montgomery C; Fisk JE; Roberts CA
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
    Roberts CA; Wetherell MA; Fisk JE; Montgomery C
    Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C; Fisk JE; Wareing M; Murphy P
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G; Redman J
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.